Skip to main content
Erschienen in: Langenbeck's Archives of Surgery 3/2006

01.06.2006 | Original Article

Pre-emptive antibiotic treatment vs ‘standard’ treatment in patients with elevated serum procalcitonin levels after elective colorectal surgery: a prospective randomised pilot study

verfasst von: Ansgar Michael Chromik, Frank Endter, Waldemar Uhl, Arnulf Thiede, Hans Bernd Reith, Ulrich Mittelkötter

Erschienen in: Langenbeck's Archives of Surgery | Ausgabe 3/2006

Einloggen, um Zugang zu erhalten

Abstract

Background

Procalcitonin (PCT) is regarded as a specific indicator of bacterial infection. Infectious complications in patients after colorectal surgery are a common cause of morbidity and mortality. The aim of this study was to investigate (a) whether PCT could serve as a negative predictive marker for postoperative complications and (b) whether, in patients with elevated PCT levels, a pre-emptive treatment with the third-generation cephalosporin ceftriaxone is superior to an antibiotic treatment starting later on the appearance of clinical signs and symptoms of infection.

Patients and methods

By screening 250 patients with colorectal surgery, we identified 20 patients with PCT serum levels more than 1.5 ng/ml on at least 2 of the first 3 postoperative days. The remaining 230 patients were followed-up for the occurrence of infectious complications. The 20 patients with elevated PCT were included in a prospective randomised pilot study comparing pre-emptive antibiotic treatment with ceftriaxone vs standard treatment.

Results

The negative predictive value of PCT for systemic infectious complications was 98.3%. In patients receiving pre-emptive antibiotic treatment (ceftriaxone), both the incidence and the severity of postoperative systemic infections were significantly lower compared to those in a control group (Pearson’s χ 2 test; p=0.001 and p=0.007, respectively). Major differences were also observed with respect to duration of antibiotic treatment and length of hospital stay.

Conclusions

PCT is an early marker for systemic infectious complications after colorectal surgery with a high negative predictive value. A significant reduction in the rate of postoperative infections in patients with elevated PCT serum concentrations was achieved by means of pre-emptive antibiotic treatment.
Literatur
1.
Zurück zum Zitat Fowler CL, Pattisapu R, Johnson LM, Assimacopoulos C, Halverson K (1988) Complications of colorectal surgery. A review of factors affecting surgical complication in 411 colorectal procedures. S D J Med 41:19–23PubMed Fowler CL, Pattisapu R, Johnson LM, Assimacopoulos C, Halverson K (1988) Complications of colorectal surgery. A review of factors affecting surgical complication in 411 colorectal procedures. S D J Med 41:19–23PubMed
2.
Zurück zum Zitat Kingston RD, Jeacock J, Walsh S, Keeling F (1995) The outcome of surgery for colorectal cancer in the elderly: a 12-year review from the Trafford Database. Eur J Surg Oncol 21:514–516CrossRefPubMed Kingston RD, Jeacock J, Walsh S, Keeling F (1995) The outcome of surgery for colorectal cancer in the elderly: a 12-year review from the Trafford Database. Eur J Surg Oncol 21:514–516CrossRefPubMed
3.
Zurück zum Zitat Urbach DR, Kennedy ED, Cohen MM (1999) Colon and rectal anastomoses do not require routine drainage: a systematic review and meta-analysis. Ann Surg 229:174–180CrossRefPubMed Urbach DR, Kennedy ED, Cohen MM (1999) Colon and rectal anastomoses do not require routine drainage: a systematic review and meta-analysis. Ann Surg 229:174–180CrossRefPubMed
4.
Zurück zum Zitat Daly JM, DeCosse JJ (1983) Complications in surgery of the colon and rectum. Surg Clin North Am 63:1215–1231PubMed Daly JM, DeCosse JJ (1983) Complications in surgery of the colon and rectum. Surg Clin North Am 63:1215–1231PubMed
5.
Zurück zum Zitat Song F, Glenny AM (1998) Antimicrobial prophylaxis in colorectal surgery: a systematic review of randomized controlled trials. Br J Surg 85:1232–1241CrossRefPubMed Song F, Glenny AM (1998) Antimicrobial prophylaxis in colorectal surgery: a systematic review of randomized controlled trials. Br J Surg 85:1232–1241CrossRefPubMed
6.
Zurück zum Zitat Zanella E, Rulli F (2000) A multicenter randomized trial of prophylaxis with intravenous cefepime + metronidazole or ceftriaxone + metronidazole in colorectal surgery. The 230 Study Group. J Chemother 12:63–71PubMed Zanella E, Rulli F (2000) A multicenter randomized trial of prophylaxis with intravenous cefepime + metronidazole or ceftriaxone + metronidazole in colorectal surgery. The 230 Study Group. J Chemother 12:63–71PubMed
7.
Zurück zum Zitat Woodfield JC, Van Rij AM, Pettigrew RA, van der Linden AJ, Solomon C, Bolt D (2003) A comparison of the prophylactic efficacy of ceftriaxone and cefotaxime in abdominal surgery. Am J Surg 185:45–49CrossRefPubMed Woodfield JC, Van Rij AM, Pettigrew RA, van der Linden AJ, Solomon C, Bolt D (2003) A comparison of the prophylactic efficacy of ceftriaxone and cefotaxime in abdominal surgery. Am J Surg 185:45–49CrossRefPubMed
8.
Zurück zum Zitat Horan TC, Culver DH, Gaynes RP, Jarvis WR, Edwards JR, Reid CR (1993) Nosocomial infections in surgical patients in the United States, January 1986–June 1992. National Nosocomial Infections Surveillance (NNIS) System. Infect Control Hosp Epidemiol 14:73–80PubMedCrossRef Horan TC, Culver DH, Gaynes RP, Jarvis WR, Edwards JR, Reid CR (1993) Nosocomial infections in surgical patients in the United States, January 1986–June 1992. National Nosocomial Infections Surveillance (NNIS) System. Infect Control Hosp Epidemiol 14:73–80PubMedCrossRef
9.
Zurück zum Zitat Arozullah AM, Khuri SF, Henderson WG, Daley J (2001) Development and validation of a multifactorial risk index for predicting postoperative pneumonia after major noncardiac surgery. Ann Intern Med 135:847–857PubMed Arozullah AM, Khuri SF, Henderson WG, Daley J (2001) Development and validation of a multifactorial risk index for predicting postoperative pneumonia after major noncardiac surgery. Ann Intern Med 135:847–857PubMed
10.
Zurück zum Zitat Johnson CC, Baldessarre J, Levison ME (1997) Peritonitis: update on pathophysiology, clinical manifestations, and management. Clin Infect Dis 24:1035–1045; quiz 1046–1037PubMedCrossRef Johnson CC, Baldessarre J, Levison ME (1997) Peritonitis: update on pathophysiology, clinical manifestations, and management. Clin Infect Dis 24:1035–1045; quiz 1046–1037PubMedCrossRef
11.
Zurück zum Zitat Grant SW, Hopkins J, Wilson SE (1995) Operative site bacteriology as an indicator of postoperative infectious complications in elective colorectal surgery. Am Surg 61:856–861PubMed Grant SW, Hopkins J, Wilson SE (1995) Operative site bacteriology as an indicator of postoperative infectious complications in elective colorectal surgery. Am Surg 61:856–861PubMed
12.
Zurück zum Zitat The Norwegian Study Group for Colorectal Surgery (1985) Should antimicrobial prophylaxis in colorectal surgery include agents effective against both anaerobic and aerobic microorganisms? A double-blind, multicenter study. Surgery 97:402–408 The Norwegian Study Group for Colorectal Surgery (1985) Should antimicrobial prophylaxis in colorectal surgery include agents effective against both anaerobic and aerobic microorganisms? A double-blind, multicenter study. Surgery 97:402–408
13.
Zurück zum Zitat Mittelkotter U (2001) Antimicrobial prophylaxis for abdominal surgery: is there a need for metronidazole? J Chemother 13(Spec No 1):27–34PubMed Mittelkotter U (2001) Antimicrobial prophylaxis for abdominal surgery: is there a need for metronidazole? J Chemother 13(Spec No 1):27–34PubMed
14.
Zurück zum Zitat Rau HG, Mittelkotter U, Zimmermann A, Lachmann A, Kohler L, Kullmann KH (2000) Perioperative infection prophylaxis and risk factor impact in colon surgery. Chemotherapy 46:353–363CrossRefPubMed Rau HG, Mittelkotter U, Zimmermann A, Lachmann A, Kohler L, Kullmann KH (2000) Perioperative infection prophylaxis and risk factor impact in colon surgery. Chemotherapy 46:353–363CrossRefPubMed
15.
Zurück zum Zitat Bone RC (1996) Immunologic dissonance: a continuing evolution in our understanding of the Systemic Inflammatory Response Syndrome (SIRS) and the Multiple Organ Dysfunction Syndrome (MODS). Ann Intern Med 125:680–687PubMed Bone RC (1996) Immunologic dissonance: a continuing evolution in our understanding of the Systemic Inflammatory Response Syndrome (SIRS) and the Multiple Organ Dysfunction Syndrome (MODS). Ann Intern Med 125:680–687PubMed
16.
Zurück zum Zitat Al-Nawas B, Krammer I, Shah PM (1996) Procalcitonin in diagnosis of severe infections. Eur J Med Res 1:331–333PubMed Al-Nawas B, Krammer I, Shah PM (1996) Procalcitonin in diagnosis of severe infections. Eur J Med Res 1:331–333PubMed
17.
Zurück zum Zitat Al-Nawas B, Shah P (1997) Procalcitonin in acute malaria. Eur J Med Res 2:206–208PubMed Al-Nawas B, Shah P (1997) Procalcitonin in acute malaria. Eur J Med Res 2:206–208PubMed
18.
Zurück zum Zitat Snider RH Jr, Nylen ES, Becker KL (1997) Procalcitonin and its component peptides in systemic inflammation: immunochemical characterization. J Investig Med 45:552–560PubMed Snider RH Jr, Nylen ES, Becker KL (1997) Procalcitonin and its component peptides in systemic inflammation: immunochemical characterization. J Investig Med 45:552–560PubMed
19.
Zurück zum Zitat Gendrel D, Raymond J, Assicot M, Moulin F, Iniguez JL, Lebon P, Bohuon C (1997) Measurement of procalcitonin levels in children with bacterial or viral meningitis. Clin Infect Dis 24:1240–1242PubMedCrossRef Gendrel D, Raymond J, Assicot M, Moulin F, Iniguez JL, Lebon P, Bohuon C (1997) Measurement of procalcitonin levels in children with bacterial or viral meningitis. Clin Infect Dis 24:1240–1242PubMedCrossRef
20.
Zurück zum Zitat Viallon A, Zeni F, Lambert C, Pozzetto B, Tardy B, Venet C, Bertrand JC (1999) High sensitivity and specificity of serum procalcitonin levels in adults with bacterial meningitis. Clin Infect Dis 28:1313–1316PubMedCrossRef Viallon A, Zeni F, Lambert C, Pozzetto B, Tardy B, Venet C, Bertrand JC (1999) High sensitivity and specificity of serum procalcitonin levels in adults with bacterial meningitis. Clin Infect Dis 28:1313–1316PubMedCrossRef
21.
Zurück zum Zitat Zeni F, Viallon A, Assicot M (1994) Procalcitonin serum concentration and severity of sepsis. Clin Intensive Care 5:89–98 Zeni F, Viallon A, Assicot M (1994) Procalcitonin serum concentration and severity of sepsis. Clin Intensive Care 5:89–98
22.
Zurück zum Zitat Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C (1993) High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 341:515–518CrossRefPubMed Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C (1993) High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 341:515–518CrossRefPubMed
23.
Zurück zum Zitat Muller B, Becker KL, Schachinger H, Rickenbacher PR, Huber PR, Zimmerli W, Ritz R (2000) Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 28:977–983CrossRefPubMed Muller B, Becker KL, Schachinger H, Rickenbacher PR, Huber PR, Zimmerli W, Ritz R (2000) Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 28:977–983CrossRefPubMed
24.
Zurück zum Zitat Wanner GA, Keel M, Steckholzer U, Beier W, Stocker R, Ertel W (2000) Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients. Crit Care Med 28:950–957CrossRefPubMed Wanner GA, Keel M, Steckholzer U, Beier W, Stocker R, Ertel W (2000) Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients. Crit Care Med 28:950–957CrossRefPubMed
25.
Zurück zum Zitat Moulin F, Raymond J, Lorrot M, Marc E, Coste J, Iniguez JL, Kalifa G, Bohuon C, Gendrel D (2001) Procalcitonin in children admitted to hospital with community acquired pneumonia. Arch Dis Child 84:332–336CrossRefPubMed Moulin F, Raymond J, Lorrot M, Marc E, Coste J, Iniguez JL, Kalifa G, Bohuon C, Gendrel D (2001) Procalcitonin in children admitted to hospital with community acquired pneumonia. Arch Dis Child 84:332–336CrossRefPubMed
26.
Zurück zum Zitat Nylen ES, Snider RH Jr, Thompson KA, Rohatgi P, Becker KL (1996) Pneumonitis-associated hyperprocalcitoninemia. Am J Med Sci 312:12–18CrossRefPubMed Nylen ES, Snider RH Jr, Thompson KA, Rohatgi P, Becker KL (1996) Pneumonitis-associated hyperprocalcitoninemia. Am J Med Sci 312:12–18CrossRefPubMed
27.
Zurück zum Zitat Bernard L, Ferriere F, Casassus P, Malas F, Leveque S, Guillevin L, Lortholary O (1998) Procalcitonin as an early marker of bacterial infection in severely neutropenic febrile adults. Clin Infect Dis 27:914–915PubMedCrossRef Bernard L, Ferriere F, Casassus P, Malas F, Leveque S, Guillevin L, Lortholary O (1998) Procalcitonin as an early marker of bacterial infection in severely neutropenic febrile adults. Clin Infect Dis 27:914–915PubMedCrossRef
28.
Zurück zum Zitat Rau B, Kruger CM, Schilling MK (2004) Procalcitonin: improved biochemical severity stratification and postoperative monitoring in severe abdominal inflammation and sepsis. Langenbecks Arch Surg 389:134–144CrossRefPubMed Rau B, Kruger CM, Schilling MK (2004) Procalcitonin: improved biochemical severity stratification and postoperative monitoring in severe abdominal inflammation and sepsis. Langenbecks Arch Surg 389:134–144CrossRefPubMed
29.
Zurück zum Zitat Reith HB, Mittelkotter U, Wagner R, Thiede A (2000) Procalcitonin (PCT) in patients with abdominal sepsis. Intensive Care Med 26:165–169CrossRef Reith HB, Mittelkotter U, Wagner R, Thiede A (2000) Procalcitonin (PCT) in patients with abdominal sepsis. Intensive Care Med 26:165–169CrossRef
30.
Zurück zum Zitat Reith HB, Mittelkotter U, Debus ES, Kussner C, Thiede A (1998) Procalcitonin in early detection of postoperative complications. Dig Surg 15:260–265CrossRefPubMed Reith HB, Mittelkotter U, Debus ES, Kussner C, Thiede A (1998) Procalcitonin in early detection of postoperative complications. Dig Surg 15:260–265CrossRefPubMed
31.
Zurück zum Zitat American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference (1992) definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864–874CrossRef American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference (1992) definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864–874CrossRef
32.
Zurück zum Zitat Carrol ED, Thomson AP, Hart CA (2002) Procalcitonin as a marker of sepsis. Int J Antimicrob Agents 20:1–9CrossRefPubMed Carrol ED, Thomson AP, Hart CA (2002) Procalcitonin as a marker of sepsis. Int J Antimicrob Agents 20:1–9CrossRefPubMed
33.
Zurück zum Zitat Al-Nawas B, Shah PM (1996) Procalcitonin in patients with and without immunosuppression and sepsis. Infection 24:434–436CrossRefPubMed Al-Nawas B, Shah PM (1996) Procalcitonin in patients with and without immunosuppression and sepsis. Infection 24:434–436CrossRefPubMed
34.
Zurück zum Zitat Engel A, Steinbach G, Kern P, Kern WV (1999) Diagnostic value of procalcitonin serum levels in neutropenic patients with fever: comparison with interleukin-8. Scand J Infect Dis 31:185–189CrossRefPubMed Engel A, Steinbach G, Kern P, Kern WV (1999) Diagnostic value of procalcitonin serum levels in neutropenic patients with fever: comparison with interleukin-8. Scand J Infect Dis 31:185–189CrossRefPubMed
35.
Zurück zum Zitat Meisner M, Tschaikowsky K, Hutzler A, Schick C, Schuttler J (1998) Postoperative plasma concentrations of procalcitonin after different types of surgery. Intensive Care Med 24:680–684CrossRefPubMed Meisner M, Tschaikowsky K, Hutzler A, Schick C, Schuttler J (1998) Postoperative plasma concentrations of procalcitonin after different types of surgery. Intensive Care Med 24:680–684CrossRefPubMed
36.
Zurück zum Zitat Molter GP, Soltesz S, Kottke R, Wilhelm W, Biedler A, Silomon M (2003) Procalcitonin plasma concentrations and systemic inflammatory response following different types of surgery. Anaesthesist 52:210–217CrossRefPubMed Molter GP, Soltesz S, Kottke R, Wilhelm W, Biedler A, Silomon M (2003) Procalcitonin plasma concentrations and systemic inflammatory response following different types of surgery. Anaesthesist 52:210–217CrossRefPubMed
37.
Zurück zum Zitat Di Filippo A, Lombardi A, Ognibene A, Messeri G, Tonelli F (2002) Procalcitonin as an early marker of postoperative infectious complications. Minerva Chir 57:59–62PubMed Di Filippo A, Lombardi A, Ognibene A, Messeri G, Tonelli F (2002) Procalcitonin as an early marker of postoperative infectious complications. Minerva Chir 57:59–62PubMed
38.
Zurück zum Zitat Schwenk W, Haase O, Raue W, Neudecker J, Muller JM (2004) Establishing “fast-track”-colonic surgery in the clinical routine. Zentralbl Chir 129:502–509CrossRefPubMed Schwenk W, Haase O, Raue W, Neudecker J, Muller JM (2004) Establishing “fast-track”-colonic surgery in the clinical routine. Zentralbl Chir 129:502–509CrossRefPubMed
39.
Zurück zum Zitat Delaney CP, Fazio VW, Senagore AJ, Robinson B, Halverson AL, Remzi FH (2001) ‘Fast track’ postoperative management protocol for patients with high co-morbidity undergoing complex abdominal and pelvic colorectal surgery. Br J Surg 88:1533–1538CrossRefPubMed Delaney CP, Fazio VW, Senagore AJ, Robinson B, Halverson AL, Remzi FH (2001) ‘Fast track’ postoperative management protocol for patients with high co-morbidity undergoing complex abdominal and pelvic colorectal surgery. Br J Surg 88:1533–1538CrossRefPubMed
Metadaten
Titel
Pre-emptive antibiotic treatment vs ‘standard’ treatment in patients with elevated serum procalcitonin levels after elective colorectal surgery: a prospective randomised pilot study
verfasst von
Ansgar Michael Chromik
Frank Endter
Waldemar Uhl
Arnulf Thiede
Hans Bernd Reith
Ulrich Mittelkötter
Publikationsdatum
01.06.2006
Verlag
Springer-Verlag
Erschienen in
Langenbeck's Archives of Surgery / Ausgabe 3/2006
Print ISSN: 1435-2443
Elektronische ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-005-0009-1

Weitere Artikel der Ausgabe 3/2006

Langenbeck's Archives of Surgery 3/2006 Zur Ausgabe

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Wie sieht der OP der Zukunft aus?

04.05.2024 DCK 2024 Kongressbericht

Der OP in der Zukunft wird mit weniger Personal auskommen – nicht, weil die Technik das medizinische Fachpersonal verdrängt, sondern weil der Personalmangel es nötig macht.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Recycling im OP – möglich, aber teuer

02.05.2024 DCK 2024 Kongressbericht

Auch wenn sich Krankenhäuser nachhaltig und grün geben – sie tragen aktuell erheblich zu den CO2-Emissionen bei und produzieren jede Menge Müll. Ein Pilotprojekt aus Bonn zeigt, dass viele Op.-Abfälle wiederverwertet werden können.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.